Latest Human subject research Stories
Reforms needed to rebuild public trust in clinical trials There is worldwide concern in the biomedical research community that enrollment in clinical trials is lagging, putting clinical research and consequent benefits to society in jeopardy. Experts explore ways to embed patient voices and values in clinical research in the current issue of Mayo Clinic Proceedings. Clinical trials of new drugs, devices, or procedures require the active participation of human volunteers. Mark A....
Recommends that multiple steps must be taken before ethical pediatric anthrax vaccine trials can be considered by the US government In a report released today, the Presidential Commission for the Study of Bioethical Issues concluded that the federal government would have to take multiple steps before anthrax vaccine trials with children could be ethically considered. The Bioethics Commission was responding to a request from Health and Human Services Secretary Kathleen Sebelius who last...
NEW YORK, June 5, 2012 /PRNewswire/ -- Arsenal Capital Partners, a leading New York-based private equity firm that invests in middle market healthcare, specialty industrial, and financial services companies, announced today the acquisition of Copernicus Group Institutional Review Board (CGIRB), a provider of compliance services which play an integral role in the clinical trial process for new drugs and medical devices. Copernicus IRB, established in 1996, is a leading independent...
NEW YORK, March 1, 2012 /PRNewswire/ -- Arsenal Capital Partners, a leading New York-based private equity firm that invests in middle market healthcare, specialty industrial, and financial services companies, announced today the acquisition of Western Institutional Review Board (WIRB), a provider of information-based services which play an integral role in the clinical trial process for new drugs and medical devices. WIRB is the leading independent institutional review board (IRB)...
CAMBRIDGE, Mass., Jan. 18, 2012 /PRNewswire/ -- At universities, hospital systems and government agencies large and small, ethics review boards tasked with overseeing the protection of human subjects in research are actively working to improve the timeliness, accuracy, and quality of reviews and research oversight. These Institutional Review Boards (IRBs) are under tremendous obligation from federal regulation and face intense pressure from medical device and drug companies...
Parker Waichman LLP Pledges to Continue its Fight on Behalf of Guatemalans who were Allegedly Infected with Syphilis and Other Sexually Transmitted Diseases In the Course of Non-Consensual Medical Experiments Conducted by U.S. Government Researchers in the 1940s. New York, New York (PRWEB) January 11, 2012 Parker Waichman LLP, a national law firm, opposes motions recently filed by the U.S. Department of Justice to dismiss a proposed individual and class action lawsuit seeking reparations...
BETHESDA, Md., Dec. 20, 2011 /PRNewswire/ -- Awards for Excellence in Human Research Protection for 2011 were announced today by Dr. Peter G. Goldschmidt, President and Founder of the Health Improvement Institute. Winner of the Annual Award for Best Practice was: Harvard Catalyst | The Harvard Clinical and Translational Science Center, Harvard Medical School (Boston, MA) for its best practice, Harvard Catalyst Master Common Reciprocal Institutional Review Board (IRB) Reliance...
CAMBRIDGE, Mass., Dec. 19, 2011 /PRNewswire/ -- At universities, hospital systems and government agencies large and small, ethics review boards tasked with overseeing the protection of human subjects in research are continuously working to improve the quality of reviews and research oversight. These Institutional Review Boards (IRBs) are under tremendous obligation from federal regulation and face intense pressure from medical device and drug companies pushing to complete...
Current regulations are robust, but should be improved The Presidential Commission for the Study of Bioethical Issues today issued its report concerning federally-sponsored research involving human volunteers, concluding that current rules and regulations provide adequate safeguards to mitigate risk. In its report, "Moral Science: Protecting Participants in Human Subjects Research," the Commission also recommended 14 changes to current practices to better protect research subjects, and...
CINCINNATI, Dec. 5, 2011 /PRNewswire/ -- Schulman Associates Institutional Review Board, Inc. announces the acquisition of Florida-based Independent Investigational Review Board, Inc. The transaction allows both organizations, which protect the rights of human research subjects, to provide a more comprehensive suite of review services for pharmaceutical, medical device, Contract Research Organization (CRO) and clinical research site customers. "The strengths of the two...
